NIH-funded research R01 grant

Investigating a new method to monitor dopamine receptors in schizophrenia treatment

Official title: Imaging the Functional State of the D2high Receptor in drug induced dopamine supersensitivity in schizophrenia

Funded at Mclean Hospital · NIH-11045785 · Data updated 2026-11-12

This study is looking at a new way to track certain brain receptors in people with schizophrenia who might be affected by their medication, using a special compound and advanced imaging techniques to make sure it's safe and effective before trying it in humans, with the hope of improving how we manage schizophrenia symptoms.

More Schizophrenia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMclean Hospital
NIH-funded
Lab location1 site (Belmont, United States)
Project startMarch 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$513,604
NIH project number5R01MH134074-02
Project IDNIH-11045785 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with schizophrenia who are currently receiving antipsychotic treatment.

Less likely to help

Patients who do not have a diagnosis of schizophrenia or are not on antipsychotic medications may not benefit from this research.

What this research studies

This research focuses on understanding how to effectively monitor dopamine D2high receptors in patients with schizophrenia who may experience dopamine supersensitivity due to antipsychotic medications. By using a specially developed D2high receptor agonist, MCL-524, and advanced imaging techniques like positron emission tomography (PET), the study aims to ensure the safety and effectiveness of this approach before it is tested in humans. The research involves preclinical experiments in animal models to evaluate the binding properties and safety of the compound, which could lead to better management of schizophrenia symptoms.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies for schizophrenia, minimizing the risk of worsening symptoms due to medication.

How similar studies have gone: Other research has shown promise in using advanced imaging techniques to monitor receptor activity, suggesting that this approach could be effective.

Where this research is happening

  • Mclean Hospital
    Belmont, United States
    Active

Researchers

  • Principal investigator: Subburaju, Sivan — Mclean Hospital
  • Study coordinator: Subburaju, Sivan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.